How Has The Autotransfusion Devices Market Size Evolved Historically?
The autotransfusion devices market has seen considerable growth due to a variety of factors.
•The market size for autotransfusion devices has seen robust growth recently. There will be a progression from $1.21 billion in 2024 to $1.27 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%.
The significant development observed during the historic period was influenced by a surge in surgical operations, the prevalence of cardiovascular diseases, orthopedic surgeries and joint replacements, emphasis on patient safety, and initiatives to cut down the expenses related to blood transfusion.
What Will Be The Autotransfusion Devices Market Size In The Future?
The autotransfusion devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market for autotransfusion devices is projected to experience significant growth in the coming years, reaching a value of $1.67 billion in 2029 with a compound annual growth rate (CAGR) of 7.0%.
This expansion during the forecast period can be linked to factors such as an increasing aging population, the broadening of ambulatory surgical centers, an emphasis on blood conservation in obstetrics and adoption in evolving healthcare markets. Key trends in the forecast period consist of advancements in blood processing technology, incorporation of sophisticated sensors, customization for different procedures, the development of closed-loop systems for single donors, and the downsizing of devices.
What Are The Key Drivers Fueling Growth In The Autotransfusion Devices Market?
The rise in cardiovascular diseases is anticipated to drive the expansion of the autotransfusion device market. These diseases encompass a range of disorders that affect the heart and blood vessels. Autotransfusion devices play a significant role in reducing the dependence on allogeneic blood transfusions, which involve blood donated from external sources. Autotransfusion facilitates the reinfusion of the patient's own blood, thus minimizing the possibility of transfusion reactions and complications linked to donor blood. To illustrate, the Heart Disease and Stroke Statistics-2022 Update report by the American Heart Association, a US-based non-profit, reveals that cardiovascular diseases continue to be the top global cause of death, claiming approximately 17.9 million lives annually. Hence, the growing incidence of cardiovascular diseases is fueling the autotransfusion device market's growth.
What Are The Principal Market Segments In The Global Autotransfusion Devices Industry?
The autotransfusion devices market covered in this report is segmented –
1) By Product Type: Autotransfusion Systems, Consumables And Accessories
2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) By End-Use: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Autotransfusion Systems: Surgical Autotransfusion Systems, Emergency Autotransfusion Systems, Continuous Flow Autotransfusion Systems
2) By Consumables And Accessories: Collection Reservoirs, Blood Filters, Tubing Sets, Pumps, Anticoagulants
Pre-Book The Autotransfusion Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Autotransfusion Devices Sector?
In an attempt to improve accuracy, efficiency, and resultant patient outcomes during blood transfusions, chief organizations in the autotransfusion devices market are concentrating their efforts on constructing highly advanced solutions such as next-gen intelligent control software. This software pertains to innovational algorithms designed to improve real-time blood retrieval, processing, and refilling, thereby ameliorating not only efficiency but also patient safety. For instance, Haemonetics Corporation, a prominent provider of blood and plasma resources and services from the US, revealed that their Cell Saver Elite+ Autotransfusion System, equipped with the next-gen software, received clearance from the FDA in March 2023. This system, optimized for recovering red blood cells during surgical interventions causing medium to extreme blood loss, presents a key advancement in autotransfusion technology. Not only does it make procedures less complex, but it also minimizes unwarranted allogeneic transfusions and enhances patient outcomes.
Who Are the Key Players in the Autotransfusion Devices Market?
Major companies operating in the autotransfusion devices market include:
• Becton Dickinson And Company
• Medtronic plc
• LivaNova plc
• Haemonetics Corporation
• Fresenius SE & Co KGaA
• Terumo Corporation
• Asahi Kasei Medical Co. Ltd.
• B. Braun Melsungen AG
• GE HealthCare Technologies Inc.
• Cerus Corporation
• Stryker Corporation
• Atrium Medical Technologies
• Brightwake Ltd.
• Getinge AB
• Beijing ZKSK Technology Co. Ltd.
• Braile Biomédica
• Redax S.p.A.
• Teleflex Incorporated
• Zimmer Biomet Holdings Inc.
• Gen World Medical Devices Corporation
• Soma Technology International LLC
• Beijing Jingjing Medical Equipment Co. Ltd.
• Johnson & Johnson Inc.
• Sorin Group
• Baxter International Inc.
• Dideco
• Nipro Corporation
What are the Regional Insights into the Autotransfusion Devices Market?
North America was the largest region in the autotransfusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
